March 26, 2026 Critical Path Institute Launches ‘One to Millions’ to Reshape the Future of Individualized Medicine at Global Scale C-Path today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative...
March 24, 2026 C-Path Taps Veteran Health Technology Leader to Drive Data and AI Strategy as Chief Data and Technology Officer C-Path today announced the appointment of Christopher Lunt as its Chief Data and Technology Officer.
March 23, 2026 Critical Path Institute and Collaborators Honored with Society of Toxicology Science Paper of the Year Award TUCSON, Ariz., March 23, 2026 — Critical Path Institute® (C-Path) announced today that the Society of Toxicology (SOT)...
March 17, 2026 PBC Ireland Partners with C-Path’s Rare Disease Data Platform, Advancing Research Efforts for Primary Biliary Cholangitis TUCSON, Ariz., March 12, 2026 — In a significant step to enhance research efforts for Primary Biliary Cholangitis...
March 10, 2026 New Study on Early Parkinson’s Disease Progression Highlights Vital Role of Patient Focused Drug Development and Real-World Impacts TUCSON, Ariz., March 5, 2026 – Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of...
March 3, 2026 Critical Path Institute’s Translational Therapeutics Accelerator Awards Grant to Support Development of Novel Nonopioid Pain Therapeutics TUCSON, Ariz., March 3, 2026 — Critical Path Institute’s® (C-Path) Bridging Research and Innovation in Drug Development...
February 25, 2026 C-Path Appoints Renowned Harvard Health Economist Amitabh Chandra to Board of Directors C-Path today announced the appointment of Amitabh Chandra, Ph.D., to its Board of Directors. Professor Chandra ...
January 28, 2026 C-Path’s New Clinical Pharmacology & Therapeutics Publication Highlights Real-World Impact of FDA-Qualified Urine Biomarkers for Earlier Detection of Drug-Induced Kidney Injury C-Path's Predictive Safety Testing Consortium today announced the publication of a new peer-reviewed...
January 21, 2026 C-Path’s Translational Therapeutics Accelerator Announces 2026 Request for Proposals from Academic Investigators TUCSON, Ariz., January 21, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator today...
November 24, 2025 C-Path Consortium Adds Gene Editing and Advanced Imaging Leaders to Accelerate Alpha-1 Research Beam Therapeutics and the Open Source Imaging Consortium join C-Path’s CPA-1 program, bringing gene editing innovation and...